Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sichen Yuan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Bioactive Materials|February 6, 2024
Convergence of nanomedicine and neutrophils for drug deliverySichen Yuan, Quanyin Hu
Seminars in Cancer Biology|November 21, 2025
Microbiota metabolism and immune regulation: From mechanisms to immunotherapeutic applications in cancerSichen Yuan, Alexa Bremmer, Xicheng Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 15, 2024
Convergence of Nanotechnology and Bacteriotherapy for Biomedical ApplicationsJun Liu, Sichen Yuan, Alexa Bremmer, et al.
Nature Communications|July 12, 2025
Endogenous tyrosinase-catalyzed therapeuticsYawen You, Zhaochen Guo, Yixin Wang, et al.
Biomaterials Science|July 16, 2024
Splittable systems in biomedical applicationsSichen Yuan, Alexa Bremmer, Xicheng Yang, et al.
Nature Biotechnology|December 3, 2024
Engineered platelets as targeted protein degraders and application to breast cancer modelsYu Chen, Samira Pal, Wen Li, et al.
Nature Biotechnology|January 13, 2025
Publisher Correction: Engineered platelets as targeted protein degraders and application to breast cancer modelsYu Chen, Samira Pal, Wen Li, et al.
Archives of Insect Biochemistry and Physiology|May 8, 2023
Candidate odorant-binding protein and chemosensory protein genes in the turnip aphid Lipaphis erysimiYinhui Kuang, Chaozhi Shangguan, Sichen Yuan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 2025
Programmable immunoprobiotics orchestrate antitumor immune response with Pin1 inhibition for pancreatic cancer treatmentSichen Yuan, Xicheng Yang, Alexa M Bremmer, et al.
European Journal of Pharmacology|July 27, 2021
One therapeutic approach for triple-negative breast cancer: Checkpoint kinase 1 inhibitor AZD7762 combination with neoadjuvant carboplatinHaiying Zhu, Zijian Rao, Sichen Yuan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bioactive Materials|February 6, 2024
Convergence of nanomedicine and neutrophils for drug deliverySichen Yuan, Quanyin Hu
Seminars in Cancer Biology|November 21, 2025
Microbiota metabolism and immune regulation: From mechanisms to immunotherapeutic applications in cancerSichen Yuan, Alexa Bremmer, Xicheng Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 15, 2024
Convergence of Nanotechnology and Bacteriotherapy for Biomedical ApplicationsJun Liu, Sichen Yuan, Alexa Bremmer, et al.
Nature Communications|July 12, 2025
Endogenous tyrosinase-catalyzed therapeuticsYawen You, Zhaochen Guo, Yixin Wang, et al.
Biomaterials Science|July 16, 2024
Splittable systems in biomedical applicationsSichen Yuan, Alexa Bremmer, Xicheng Yang, et al.
Nature Biotechnology|December 3, 2024
Engineered platelets as targeted protein degraders and application to breast cancer modelsYu Chen, Samira Pal, Wen Li, et al.
Nature Biotechnology|January 13, 2025
Publisher Correction: Engineered platelets as targeted protein degraders and application to breast cancer modelsYu Chen, Samira Pal, Wen Li, et al.
Archives of Insect Biochemistry and Physiology|May 8, 2023
Candidate odorant-binding protein and chemosensory protein genes in the turnip aphid Lipaphis erysimiYinhui Kuang, Chaozhi Shangguan, Sichen Yuan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 2025
Programmable immunoprobiotics orchestrate antitumor immune response with Pin1 inhibition for pancreatic cancer treatmentSichen Yuan, Xicheng Yang, Alexa M Bremmer, et al.
European Journal of Pharmacology|July 27, 2021
One therapeutic approach for triple-negative breast cancer: Checkpoint kinase 1 inhibitor AZD7762 combination with neoadjuvant carboplatinHaiying Zhu, Zijian Rao, Sichen Yuan, et al.
Pageof 2